RETRACTABLE TECHNOLOGIES INC
RVPNYSEHealthcare · Surgical & Medical Instruments & Apparatus · TX · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $38.3M | $33.0M | $43.6M | $94.8M | $188.4M | $81.9M |
| Operating income | −$21.2M | −$21.1M | −$11.5M | −$852,976 | $72.6M | $24.1M |
| Net income | −$12.6M | −$11.9M | −$7.0M | $5.1M | $56.1M | $24.2M |
| Total assets | $142.6M | $160.7M | $179.7M | $195.7M | $206.3M | $105.0M |
| Total liabilities | $68.3M | $73.6M | $80.4M | $89.1M | $107.1M | $55.1M |
| Equity | $74.4M | $87.2M | $99.3M | $106.5M | $99.2M | $49.9M |
| EPS (diluted) | $-0.43 | $-0.40 | $-0.24 | $0.15 | $1.63 | $0.80 |
| Shares out. | 29.9M | 29.9M | 29.9M | 33.1M | 34.0M | 32.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −55.3%
- Net margin
- −32.8%
- Return on equity
- −16.9%
- Return on assets
- −8.8%
- Return on capital (ROCE)
- −15.9%
- Liabilities / assets
- 47.9%
- Debt / equity
- 0.92×
- Book value / share
- $2.48
- Revenue growth (YoY)
- 15.8%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 2.92safe
- Accruals / assets
- −3.9%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 4 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 14, 2011
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Shaw Thomas JOfficer — PRESIDENT AND CEO | Oct 14, 2025 | Buy | 14,204 | $0.93 |
| Shaw Thomas JOfficer — PRESIDENT AND CEO | Oct 8, 2025 | Buy | 30,000 | $0.92 |
| Shaw Thomas JOfficer — PRESIDENT AND CEO | Sep 29, 2025 | Buy | 5,000 | $0.82 |
| Shaw Thomas JOfficer — PRESIDENT AND CEO | Sep 24, 2025 | Buy | 17,500 | $0.80 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 43,789 | 1.0 | +14.3% |
| Apr 30, 2026 | 38,317 | 1.0 | +29.9% |
| Apr 15, 2026 | 29,485 | 1.0 | -61.0% |
| Mar 31, 2026 | 75,516 | 1.3 | -1.9% |
| Mar 13, 2026 | 76,963 | 1.7 | -17.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 15, 2026
- Shareholder voteMay 13, 2026
- Other material eventApr 10, 2026
- Other material eventMar 27, 2026
- Other material eventDec 30, 2025
- Other material eventNov 14, 2025
- Other material eventSep 30, 2025
- Other material eventAug 14, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 15, 2026
- 10-QMay 15, 2026
- 8-KFORM 8-KMay 13, 2026
- 8-KFORM 8-KApr 10, 2026
- 8-KFORM 8-KMar 27, 2026
- 10-KMar 27, 2026
- DEFA14AMar 27, 2026
- DEF 14AMar 27, 2026
- 8-KFORM 8-KDec 30, 2025
- 4Nov 17, 2025
- 8-KFORM 8-KNov 14, 2025
- 10-QNov 14, 2025
- 4Nov 13, 2025
- 4Nov 6, 2025
- 4Oct 31, 2025
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.